About insulin glargine + lixisenatide
Long-acting insulin and GLP-1 receptor agonist
Used for
- Improves blood sugar control in adults with type 2 diabetes when other treatments are insufficient.
Usual adult dose
Injected under the skin once daily, within one hour before the first meal. Dose is individualized and adjusted by blood glucose; follow the product’s dosing instructions.
Common side effects
- Low blood sugar
- Nausea, vomiting, or diarrhea
- Injection-site reactions
- Dizziness or headache
Important warnings
- Not for type 1 diabetes or diabetic ketoacidosis.
- Low blood sugar risk increases with insulin or sulfonylureas.
- May cause pancreatitis; seek urgent assessment for severe, persistent abdominal pain.
- Not recommended in severe stomach-emptying problems or severe kidney disease.
Pregnancy
Not recommended during pregnancy; insulin treatment is generally preferred. Consult a clinician before use or when planning pregnancy.
Breastfeeding
Use only after clinician review; breastfeeding may require insulin dose adjustments and blood-glucose monitoring.
Interactions
- Other diabetes medicines can increase low blood sugar risk.
- Medicines that slow stomach emptying may affect absorption of oral medicines.
- Beta-blockers can mask some signs of low blood sugar.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.